Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration.

Biozentrum, University of Basel, Basel, CH-4056, Switzerland.
Cell metabolism (Impact Factor: 17.35). 12/2008; 8(5):399-410. DOI: 10.1016/j.cmet.2008.09.003
Source: PubMed

ABSTRACT raptor is a specific and essential component of mammalian TOR complex 1 (mTORC1), a key regulator of cell growth and metabolism. To investigate a role of adipose mTORC1 in regulation of adipose and whole-body metabolism, we generated mice with an adipose-specific knockout of raptor (raptor(ad-/-)). Compared to control littermates, raptor(ad-/-) mice had substantially less adipose tissue, were protected against diet-induced obesity and hypercholesterolemia, and exhibited improved insulin sensitivity. Leanness was in spite of reduced physical activity and unaffected caloric intake, lipolysis, and absorption of lipids from the food. White adipose tissue of raptor(ad-/-) mice displayed enhanced expression of genes encoding mitochondrial uncoupling proteins characteristic of brown fat. Leanness of the raptor(ad-/-) mice was attributed to elevated energy expenditure due to mitochondrial uncoupling. These results suggest that adipose mTORC1 is a regulator of adipose metabolism and, thereby, controls whole-body energy homeostasis.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Sterile alpha motif domain containing protein 4 (Samd4) is an RNA binding protein that mediates translational repression. We identified a Samd4 missense mutation, designated supermodel, that caused leanness and kyphosis associated with myopathy and adipocyte defects in C57BL/6J mice. The supermodel mutation protected homozygous mice from high fat diet-induced obesity, likely by promoting enhanced energy expenditure through uncoupled mitochondrial respiration. Glucose tolerance was impaired due to diminished insulin release in homozygous mutant mice. The defects of metabolism in supermodel mice may be explained by dysregulated mechanistic target of rapamycin complex 1 (mTORC1) signaling, evidenced by hypophosphorylation of 4E-BP1 and S6 in muscle and adipose tissues of homozygous mice. Samd4 may interface with mTORC1 signaling through an interaction with 14-3-3 proteins and with Akt, which phosphorylates Samd4 in vitro.
    Proceedings of the National Academy of Sciences 05/2014; · 9.81 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Neurons depend on their mitochondria for optimum function and become susceptible with age. Mitochondrial function is gradually impaired during aging because more electrons are converted to reactive oxygen species rather than being converted to ATP. Retinal ganglion cell mitochondria are additionally affected in glaucoma because of reduced oxygen delivery. Thus, targeting neuronal mitochondria to enhance their function as in glaucoma and aspects associated with aging provides potential ways of attenuating degenerating diseases. A substance worthy of mention is rapamycin, which affects regulated in development and DNA damage 1 (REDD1), and is known to enhance mitochondrial function. REDD1 appears to be prominent in retinal ganglion cells. An alternative exciting non-invasive approach is to use red light therapy that enhances mitochondrial function.
    Drug discovery today. 05/2014;
  • Source
    Brian J Morris, Bruce A Carnes, Timothy A Donlon, Qimeihe, John S Grove, Kamal H Masaki, Ayakoelliott, Donald C Willcox, Bradley J Willcox
    [Show abstract] [Hide abstract]
    ABSTRACT: Essential hypertension (EHT) increases in prevalence from middle age onward. In the elderly, isolated systolic hyper-tension (ISH) is a common condition. Acharacteristic fea-ture of hypertension is hypertrophy of vascular and cardiac smooth muscle. This feature ties in with the hyperfunction theory of aging, which postulates that in later life the once beneficial processes that contributed to the growth of the organism early in life become deleterious because of their contribution to pathologies characterized by hypertrophy and hyperplasia. 1 Based on data from model organisms, the major mechanisms involved in hypertrophy and hyperpla-sia include key growth stimulating pathways, particularly those involving insulin/IGF-1 signaling and the mechanistic (formerly "mammalian") target of rapamycin (mTOR) com-plex 1, which are pivotal to exacerbation of age-dependent chronic conditions. 1–4 To date, the role of these intracellular pathways in overweight and hypertension has received little attention. Background The mechanistic target of rapamycin (mTOR) pathway is pivotal for cell growth. Regulatory associated protein of mTOR complex I (Raptor) is a unique component of this pro-growth complex. The present study tested whether variation across the raptor gene (RPTOR) is associated with overweight and hypertension.
    American Journal of Hypertension 05/2014; 1. · 3.67 Impact Factor

Full-text (3 Sources)

Available from
Jun 5, 2014